Loading comparison data...
Compare ADALIMUMAB-AATY (Yuflyma) and ADALIMUMAB-ADAZ (HYRIMOZ) — clinical data, side effects, and patient experiences.
Yuflyma · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
HYRIMOZ · TNF Inhibitor
How it works
12.1 Mechanism of Action Adalimumab products bind specifically to TNF-alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse...
Approved for
Estimated frequency (%) based on clinical trial data
Based on 2 Reddit discussions
ADALIMUMAB-AATY
0%
positive
2 threads
ADALIMUMAB-ADAZ
0%
positive
0 threads
2 Reddit threads analysed for ADALIMUMAB-AATY
Overall Sentiment
Mixed
Comparison Threads
0
Avg Post Score
3 upvotes
Just received a letter that my company will no longer cover Humira and for my adult child UC and offered generic adalimumab aaty or adalimumab-adaz instead. When first diagnosed, my adult child went through 3 different drugs until we found the right match that finally gave her life back and another
Hello Everyone! My insurance recently switched me from Humira to Adalimumab-aaty, which is a biosimilar. When I was taking Humira I barely felt the injection, but the adalimumab injections REALLY hurt! Has anyone else had this experience?? Any tips?
Community discussions are sourced from public Reddit threads. Content reflects individual opinions and is not medical advice.
No community discussions found for ADALIMUMAB-ADAZ yet.
Both ADALIMUMAB-AATY and ADALIMUMAB-ADAZ belong to the TNF Inhibitor class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. ADALIMUMAB-AATY is administered via Oral, whereas ADALIMUMAB-ADAZ uses Subcutaneous. Route of administration can affect onset of action and patient adherence.
Both medications are approved for inducing major clinical response, inhibiting the progression of structural damage, inhibiting the progression of structural damage, posterior. When two drugs treat the same condition, the choice between them often depends on the patient's medical history, other medications, tolerability, and prescriber preference.
ADALIMUMAB-AATY carries 4 FDA warnings. ADALIMUMAB-ADAZ carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..
This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.
Every figure on this comparison links back to its primary source. See data sources and methodology for the full provenance trail.